Perphenazine
Perphenazine is a pharmaceutical drug with 14 clinical trials. Historical success rate of 81.8%.
Success Metrics
Based on 9 completed trials
Phase Distribution
Phase Distribution
1
Early Stage
2
Mid Stage
9
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
75.0%
9 of 12 finished
25.0%
3 ended early
0
trials recruiting
14
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Recommendations of Enhanced Recovery Interventions for Patient's Clinical Team and Collection of Associated Data
A Study to Compare Disease Progression and Modification Following Treatment With Paliperidone Palmitate Long-Acting Injection or Oral Antipsychotics in Participant's With Recent-onset Schizophrenia or Schizophreniform
Longitudinal Comparative Effectiveness of Bipolar Disorder Therapies
Networked Drug REpurposing for Mechanism-based neuroPrOtection in Acute Ischaemic STROKE
Lurasidone Effects on Tissue Glutamate in Schizophrenia
Clinical Trials (14)
Recommendations of Enhanced Recovery Interventions for Patient's Clinical Team and Collection of Associated Data
A Study to Compare Disease Progression and Modification Following Treatment With Paliperidone Palmitate Long-Acting Injection or Oral Antipsychotics in Participant's With Recent-onset Schizophrenia or Schizophreniform
Longitudinal Comparative Effectiveness of Bipolar Disorder Therapies
Networked Drug REpurposing for Mechanism-based neuroPrOtection in Acute Ischaemic STROKE
Lurasidone Effects on Tissue Glutamate in Schizophrenia
Family Intervention in Recent Onset Schizophrenia Treatment (FIRST)
Evaluation of the Necessity of Long-term Pharmacological Treatment With Antipsychotics in Schizophrenic Patients
Pharmacovigilance in Gerontopsychiatric Patients
CATIE- Schizophrenia Trial
15 Month Study for Adults Who Have Been Diagnosed With Schizophrenia and Incarcerated
Twelve Month Study Comparing Paliperidone Palmitate and Select Oral Antipsychotics in Adults With Schizophrenia Who Have Been Recently Discharged From an Inpatient Psychiatric Hospital
Comparison of Optimal Antipsychotic Treatments for Adults With Schizophrenia
A Double-Blind, Controlled Study of Aripiprazole in Co-Morbid Schizophrenia and Cocaine Dependence
A Positron Emission Tomography (PET) Study to Assess the Degree of Dopamine-2 (D2) Receptor Occupancy in the Human Brain After Single Doses of BL-1020 or Perphenazine in Healthy Male Subjects Using [11C]Raclopride as PET Tracer
All 14 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 14